University Multi-Profile Hospital for Active Treatment (UMHAT) St. Ivan Rilski

Sofia 1431

1 studies enrolling now · 2 studies all time

What they study most

Primary Immune Thrombocytopenia (ITP), Relapsing-remitting Multiple Sclerosis (RRMS)

Studies at this site

• A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia — Recruiting now
• Comparison Between ABP 692 and Ocrevus® (Ocrelizumab) — Running, not enrolling